DongKook Life Science동국생명과학
303810 · KOSDAQ · ₩303810 · 동국생명과학
₩2,145▼ ₩130 (5.71%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩130B | ₩132B |
| Cost of sales | ₩97B | ₩103B |
| Gross profit | ₩33B | ₩29B |
| Operating income | ₩13B | ₩12B |
| Net income | ₩8.7B | ₩2.2B |
| Net income to shareholders | ₩8.7B | ₩2.2B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩218B | ₩192B |
| Current assets | ₩139B | ₩116B |
| Cash and equivalents | ₩2B | ₩2.4B |
| Total liabilities | ₩86B | ₩86B |
| Current liabilities | ₩81B | ₩63B |
| Borrowings | ₩39B | ₩45B |
| Total equity | ₩131B | ₩105B |
| Shareholders' equity | ₩131B | ₩105B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | ₩434M | ₩12B |
| Capital spending | ₩5.7B | ₩5.1B |
| Free cash flow | −₩5.3B | ₩6.5B |
Consolidated where available. Amounts in won.
Also known as: DongKook Life Science / 동국생명과학 / 303810 / KRX:303810
Source: KRX statistical information